Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Pancreatic Neoplasms

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Pancreatic Neoplasms in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sigfrid, LA1
Cunningham, JM1
Beeharry, N1
Lortz, S1
Tiedge, M1
Lenzen, S1
Carlsson, C1
Green, IC1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Pancreatic Neoplasms

ArticleYear
Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells.
    Journal of molecular endocrinology, 2003, Volume: 31, Issue:3

    Topics: Amidines; Animals; Benzylamines; Catalase; Cell Death; Cytokines; Enzyme Activation; Enzyme Inhibito

2003